Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 6 years
- Director since
- 2023
6 years of board service in total across 2 boards, counting each seat separately. Longest: Kiora Pharmaceuticals Inc., 3 years.
Kiora Pharmaceuticals Inc.
Director
Contineum Therapeutics Inc.
Director · CEO and President
Chief executive roles
Contineum Therapeutics Inc.
· CEO and President
Since April 2024
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 3, 2026 | Contineum Therapeutics Inc. | Option exercise | +2,500 | $1.01 | $2,525 |
| Aug 3, 2026 | Contineum Therapeutics Inc. | Open-market sale | −2,500 | $16.01 | $40,029 |
| Jul 8, 2026 | Contineum Therapeutics Inc. | Option exercise | +2,500 | $1.01 | $2,525 |
| Jul 8, 2026 | Contineum Therapeutics Inc. | Open-market sale | −2,500 | $16.00 | $40,000 |
| Jun 30, 2026 | Contineum Therapeutics Inc. | Option exercise | +7,500 | $1.01 | $7,575 |
| Jun 30, 2026 | Contineum Therapeutics Inc. | Option exercise | +2,500 | $1.26 | $3,150 |
| Jun 30, 2026 | Contineum Therapeutics Inc. | Open-market sale | −10,000 | $16.01 | $160,080 |
| Feb 25, 2026 | Contineum Therapeutics Inc. | Option exercise | +2,700 | $1.26 | $3,402 |
| Feb 25, 2026 | Contineum Therapeutics Inc. | Open-market sale | −2,700 | $16.02 | $43,254 |
| Feb 24, 2026 | Contineum Therapeutics Inc. | Option exercise | +4,400 | $1.26 | $5,544 |
| Feb 24, 2026 | Contineum Therapeutics Inc. | Open-market sale | −4,400 | $16.02 | $70,488 |
| Feb 11, 2026 | Contineum Therapeutics Inc. | Option exercise | +400 | $1.26 | $504 |
| Feb 11, 2026 | Contineum Therapeutics Inc. | Open-market sale | −400 | $16.00 | $6,400 |
| Sep 11, 2024 | Kiora Pharmaceuticals Inc. | Open-market purchase | +1,250 | $3.68 | $4,600 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.